Evidence map›Paper›PMID 40435413›Full record

ArticleBlood2025

PERK signaling maintains hematopoietic stem cell pool integrity under endoplasmic reticulum stress by promoting proliferation.

Manxi Zheng, Qinlu Peng, Erin M Kropp, Zhejuan Shen, Suxuan Liu, Zhengyou Yin, Sho Matono, Takao Iwawaki, Xiang Wang, Ken Inoki and 3 more

Abstract read
In one paragraph

Article in Blood, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Manxi ZhengHunan Key Laboratory of Animal Models and Molecular Medicine, School of Biomedical Sciences, Hunan University, Changsha, China.
Qinlu PengHunan Key Laboratory of Animal Models and Molecular Medicine, School of Biomedical Sciences, Hunan University, Changsha, China.
Erin M KroppDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI.ORCID 0000-0002-8597-3025
Zhejuan ShenHunan Key Laboratory of Animal Models and Molecular Medicine, School of Biomedical Sciences, Hunan University, Changsha, China.
Suxuan LiuHunan Key Laboratory of Animal Models and Molecular Medicine, School of Biomedical Sciences, Hunan University, Changsha, China.
Zhengyou YinHunan Key Laboratory of Animal Models and Molecular Medicine, School of Biomedical Sciences, Hunan University, Changsha, China.
Sho MatonoDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI.
Takao IwawakiDivision of Cell Medicine, Department of Life Science, Medical Research Institute, Kanazawa Medical University, Uchinada, Japan.ORCID 0000-0001-8753-1979
Xiang WangDepartment of Food Quality and Food Safety, School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.
Ken InokiDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI.
Yang MeiHunan Key Laboratory of Animal Models and Molecular Medicine, School of Biomedical Sciences, Hunan University, Changsha, China.ORCID 0000-0002-0432-2897
Qing LiDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI.ORCID 0000-0002-4982-1024
Lu LiuHunan Key Laboratory of Animal Models and Molecular Medicine, School of Biomedical Sciences, Hunan University, Changsha, China.ORCID 0000-0001-7984-6671

Funding

ONCOLOGY RESEARCH TRAINING GRANTT32CA009357 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Qing Li · 1987 to 2026
$8.6M
The role of ER associated degradation (ERAD) in hematopoietic stem cellsR01HL150707 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LI, QING · 2020 to 2024
$2.4M
Modulation of Endoplasmic Reticulum Associated Degradation to Support Ex Vivo Expansion of Hematopoietic Stem CellsR01HL174566 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Qing Li · 2024 to 2026
$1.5M
Molecular mechanism of mTORC1-dependent translation and ribosome biogenesisR01GM110019 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI INOKI, KEN · 2015 to 2018
$1.2M
NCI NIH HHS T32 CA009357NHLBI NIH HHS R01 HL150707NHLBI NIH HHS R01 HL174566NIGMS NIH HHS R01 GM110019
6 · The paper itself

Abstract

abstractThe integrity of the hematopoietic stem cell (HSC) pool depends on effective long-term self-renewal and the timely elimination of damaged or differentiation-prone HSCs. Although the protein kinase R-like endoplasmic reticulum kinase (PERK) branch of the unfolded protein response has been shown to initiate proapoptotic signaling in response to endoplasmic reticulum (ER) stress in vitro, its role in regulating the HSC fate in vivo remains incompletely understood. Here, we demonstrated that PERK is dispensable for steady-state hematopoiesis and HSC self-renewal under homeostatic conditions. However, under ER stress induced by the disruption of ER-associated degradation (ERAD) through knockout of key components, such as Sel1L or Hrd1, PERK becomes activated and drives HSC proliferation and depletion. Notably, deletion of PERK or expression of a kinase-dead PERK mutant significantly rescued the HSC defects caused by Sel1L or Hrd1 loss. Mechanistically, an ERAD deficiency did not lead to increased HSC apoptosis or elevated reactive oxygen species, and PERK knockout had minimal impact on HSC apoptosis. Instead, PERK activation promoted aberrant mTOR (mammalian target of rapamycin) signaling and HSC hyperproliferation, ultimately compromising self-renewal capacity. This PERK-driven elimination of stressed HSCs may function as a protective mechanism to maintain the overall HSC pool integrity. Collectively, our findings reveal a previously unrecognized, proliferative, and apoptosis-independent role for PERK in regulating HSC fate under ER stress, highlighting a novel mechanism for preserving HSC homeostasis.

Indexed as

Cell ProliferationeIF-2 KinaseEndoplasmic Reticulum StressHematopoietic Stem CellsSignal TransductionAnimalsApoptosisEndoplasmic Reticulum-Associated DegradationHematopoiesisMiceMice, Inbred C57BLMice, KnockoutTOR Serine-Threonine KinasesUbiquitin-Protein LigasesUnfolded Protein ResponseeIF-2 KinaseSyvn1 protein, mouseTOR Serine-Threonine KinasesUbiquitin-Protein Ligases

Identifiers

PMID40435413
PMCPMC12883860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.